These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12205349)

  • 21. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatment for clogged coronary arteries.
    Mayo Clin Health Lett; 2002 Dec; 20(12):4. PubMed ID: 12526107
    [No Abstract]   [Full Text] [Related]  

  • 24. The conversion in application of percutaneous coronary intervention following the introduction of drug eluting stents.
    Ikeno F; Raissi Shabari F; Sadoughi A; Lyons JK; Pourdehmobed K; Hashemi V; Emami S; Kaneda H; Yeung AC; Rezaee M
    Int J Cardiol; 2006 Nov; 113(2):279-80. PubMed ID: 16318883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Aziz S; Ramsdale DR
    J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
    [No Abstract]   [Full Text] [Related]  

  • 26. The approach to small vessels in the era of drug-eluting stents.
    Holmes DR; Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S31-7. PubMed ID: 15665796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting stents: clinical perspectives on drug and design differences.
    Rogers CD
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S3-12. PubMed ID: 15665795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel technique for coronary bifurcation lesions: cutting balloons, drug-eluting stents and the kissing technique.
    Wong CB; Hardin S
    J Invasive Cardiol; 2005 Feb; 17(2):108-10. PubMed ID: 15687538
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
    Blackman DJ; Porto I; Shirodaria C; Channon KM; Banning AP
    Am J Cardiol; 2004 Oct; 94(7):922-5. PubMed ID: 15464678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.
    Liu X; De Scheerder I; Desmet W
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):653-60. PubMed ID: 15350167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overstretching undersized drug-eluting stents: a temporary solution.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
    [No Abstract]   [Full Text] [Related]  

  • 34. Complex coronary intervention in the drug-eluting stent era. Introduction.
    Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S1-2. PubMed ID: 15665792
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of BMS in the drug eluting stent era: is still there any place for them?
    Fineschi M; Gori T
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):456; author reply 457. PubMed ID: 16892446
    [No Abstract]   [Full Text] [Related]  

  • 36. Contemporary treatment of coronary bifurcations with DES: part I.
    Colombo A
    J Interv Cardiol; 2005 Oct; 18(5):351-4. PubMed ID: 16202109
    [No Abstract]   [Full Text] [Related]  

  • 37. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
    Perin EC
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could direct inhibition of inflammation be the "next big thing" in treating atherosclerosis?
    Natarajan P; Cannon CP
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2081-3. PubMed ID: 20962294
    [No Abstract]   [Full Text] [Related]  

  • 39. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.